--- title: InsightRX Precision Medicine Software Platform Selected by Amsterdam UMC description: InsightRX grows its European presence via partnership with Amsterdam UMC, a leading university medical center in the Netherlands image: https://blog.insight-rx.com/hubfs/Logo-Amsterdam-UMC-1.png --- [![InsightRX](https://blog.insight-rx.com/hubfs/insightrx_logo_white-teal.svg)](https://blog.insight-rx.com/) - For Providers - Solutions - [MIPD for Providers Explore our full solution for Bayesian model-informed dosing](https://www.insight-rx.com/mipd) - [Future of Pharmacy Learn what's next for AI in health tech, and why architecture matters](https://www.insight-rx.com/future) - Products - [InsightRX Nova Bayesian dosing (MIPD) app for bedside clinical decision support](https://www.insight-rx.com/provider/nova) - [InsightRX Apollo Real-time clinical analytics to measure outcomes](https://www.insight-rx.com/provider/apollo) - [Drug Modules Available medications for precision dosing apps](https://www.insight-rx.com/provider/drug-modules) - [For Life Sciences](https://www.insight-rx.com/life-sciences) - Overview - [InsightRX for Life Sciences Explore our solution for biopharma and clinical trial use](https://www.insight-rx.com/life-sciences) - Products - [Nova for Life Sciences Precision dosing app for clinical trial use](https://www.insight-rx.com/life-sciences/nova) - [Astra for Life Sciences AI-native environment for PK/PD modeling and simulation](https://www.insight-rx.com/life-sciences/astra) - Platform - [Continuous Learning Patented process for model retraining and improvement](https://www.insight-rx.com/platform/continuous-learning) - [Integrations Platform interoperability setup with EHRs, EDCs, and more](https://www.insight-rx.com/platform/integrations) - [Security & Regulatory Standards for product development and release](https://www.insight-rx.com/platform/security-regulatory) - [Success & Support Pharmacist-led training, onboarding, and education](https://www.insight-rx.com/platform/support) - Resources - Science - [Data Science Explore the science and learn more about our R&D](https://www.insight-rx.com/data-science) - [Scientific Publications Impactful research manuscripts with at least one InsightRX author](https://www.insight-rx.com/data-science/scientific-publications) - [How to Cite Using one of our apps? Follow this easy guide for citation in research](https://www.insight-rx.com/how-to-cite-insightrx-nova) - Explore - [Success Stories Case studies from real InsightRX customers about their journey](https://www.insight-rx.com/success-stories) - [White Papers In-depth analysis and best practices for review and download](https://blog.insight-rx.com/resources/tag/white-papers) - [Pubs. Using InsightRX Review research that has used InsightRX applications](https://www.insight-rx.com/publications-using-insightrx-software) - [Blog](https://blog.insight-rx.com/resources) - [All Blog Posts Read the latest posts by our team of experts](https://blog.insight-rx.com/resources) - [Product Innovation The latest updates on our products, services, and science](https://blog.insight-rx.com/resources?section=product_innovation) - [Thought Leadership Posts from our team of experts on PK, MIPD, science, and more](https://blog.insight-rx.com/resources?section=thought_leadership) - Company - About - [About Us Our story, what drives us and why we're passionate about our work](https://www.insight-rx.com/about) - [Leadership Founders and team leaders who strive toward excellence in MIPD](https://www.insight-rx.com/leadership) - [Advisory Board Scientists and experts to ensure our collective success](https://www.insight-rx.com/advisory-board) - [Careers Interested in joining? View available openings here](https://www.insight-rx.com/careers) - [Customers Hear what others have to say about their experience](https://www.insight-rx.com/customers) - Press - [All Stories InsightRX news, company updates, and more](https://blog.insight-rx.com/press-releases) - [Press Releases Announcements for events, partnerships, and company updates](https://blog.insight-rx.com/press-releases?section=press_releases) - [Media InsightRX in the news — digital, print, podcasts, and other outlets](https://blog.insight-rx.com/press-releases?section=media) [![Contact Us](https://no-cache.hubspot.com/cta/default/40041574/interactive-193831493462.png)](https://cta-service-cms2.hubspot.com/web-interactives/public/v1/track/redirect?encryptedPayload=AVxigLIVhNAV4frdGw7WK4%2FsUL9BSW7sTFfaUWeB6c0miW6Ak22RBUNE5R8BeaQrWqzDSork53FkrNEqiSn%2FTM4f%2BVzPNcA0Ikxp7y6GqZRUQJ2HulFNF849cXXSebQBDVQXFR3hVvn8tZ3jkxYoygqRgjFUwIOapgI0FM8UFCm2xhxz2SgLhEGqk1U%3D&webInteractiveContentId=193831493462&portalId=40041574) [![Contact Us](https://no-cache.hubspot.com/cta/default/40041574/interactive-193831493462.png)](https://cta-service-cms2.hubspot.com/web-interactives/public/v1/track/redirect?encryptedPayload=AVxigLIVhNAV4frdGw7WK4%2FsUL9BSW7sTFfaUWeB6c0miW6Ak22RBUNE5R8BeaQrWqzDSork53FkrNEqiSn%2FTM4f%2BVzPNcA0Ikxp7y6GqZRUQJ2HulFNF849cXXSebQBDVQXFR3hVvn8tZ3jkxYoygqRgjFUwIOapgI0FM8UFCm2xhxz2SgLhEGqk1U%3D&webInteractiveContentId=193831493462&portalId=40041574) Press Releases # InsightRX Precision Medicine Software Platform Selected by Amsterdam UMC - Published July 25, 2022 By [InsightRX Communications](https://blog.insight-rx.com/press-releases/author/insightrx) ![](https://blog.insight-rx.com/hubfs/Logo-Amsterdam-UMC-1.png) SAN FRANCISCO, July 25, 2022 – Today [InsightRX](https://www.insight-rx.com/), a precision dosing intelligence company, announced that Amsterdam UMC, a large university medical center in the Netherlands, is using its InsightRX Nova platform to practice model-informed precision dosing at the point of care. The center implemented InsightRX Nova across two hospital locations for inpatient therapeutic drug monitoring (TDM) as well as use in outpatient clinics. InsightRX Nova delivers dosing guidance for patients who are prescribed one of four common antibiotics, in addition to patients who are receiving busulfan as part of a conditioning regimen before a bone marrow or stem cell transplant. The medical center is also serving as an InsightRX research partner for tacrolimus, mycophenolate, and cyclosporin, which are used to combat solid organ transplant rejection. InsightRX Nova provides a preferred pharmacokinetic (PK) model for each drug as well as a selection of alternative models for key subgroups, such as obese patients or those in intensive care. The platform also provides simultaneous analysis of data at the population level as well as at the individual level; errors and outliers are transparent to users. The platform’s PK models are improved over time, and can be updated to account for specific characteristics of patients within the institute. InsightRX Nova also allows for the exploration of new covariates based on clinical hypotheses. The platform has already helped Amsterdam UMC recognize abnormally high predicted renal function levels and underpredicted vancomycin exposure among an immobile patient population, leading the team to adjust its covariate-model to correct for underprediction. > “We selected InsightRX Nova because we wanted to move to a state-of-the-art system which uses more sophisticated pharmacokinetic models, as that leads to better dosing recommendations,” said Imke Bartelink, PharmD, PhD, hospital pharmacist at Amsterdam UMC. “Now, we no longer face restrictions on adding covariates or estimating variability within the PK models, which means we are better able to improve predictions for an individual patient.” InsightRX Nova has self-certified [CE marking](https://www.nist.gov/standardsgov/compliance-faqs-ce-marking)in six European countries: Austria, Belgium, France, Germany, the Netherlands, and the United Kingdom. The platform’s CE mark was a key consideration in Amsterdam UMC’s selection process, as it confirms that InsightRX Nova meets applicable health, safety and environmental requirements and has passed European regulatory requirements and conformity procedures. Since implementing the platform in March 2022, Amsterdam UMC has trained approximately 40 clinical pharmacists on six InsightRX Nova modules, and plans to add three additional modules in the near future. An integration between Epic and InsightRX is also planned to facilitate and reduce copy errors. > “We are pleased to support Amsterdam UMC’s pharmacists as they practice model-informed precision dosing in both the inpatient and outpatient setting,” said Sirj Goswami, CEO and co-founder of InsightRX. “We look forward to continuing to grow our presence in Europe. We are eager to work with institutions like Amsterdam UMC to expand the benefits of model-informed precision dosing to other therapeutic areas, such as mycophenolate and cyclosporin.”   [implementation](https://blog.insight-rx.com/press-releases/tag/implementation) [partnerships](https://blog.insight-rx.com/press-releases/tag/partnerships) [international](https://blog.insight-rx.com/press-releases/tag/international) #### On this page… **Connect with us to get the latest blog updates, instantly sent to your inbox** ## Dig deeper. Explore related articles and additional posts on the InsightRX blog. [Press Releases Oct 11, 2022 InsightRX Offers Precision Dosing Support for New Drug Categories](https://blog.insight-rx.com/press-releases/insightrx-offers-precision-dosing-support-new-drug-categories) [Press Releases Mar 14, 2023 InsightRX Continues Accelerated Growth with Life Sciences Organizations and Health Systems](https://blog.insight-rx.com/press-releases/insightrx-continues-accelerated-growth-life-sciences-organizations-health-systems) [Press Releases May 14, 2024 InsightRX Continues Momentum in Precision Dosing with Client Growth, New Scientific Breakthroughs](https://blog.insight-rx.com/press-releases/insightrx-precision-dosing-client-growth-scientific-breakthroughs) #### What We Do ##### For Providers - [Nova (Bayesian Dosing)](https://www.insight-rx.com/provider/nova) - [Apollo (Clinical Analytics)](https://www.insight-rx.com/provider/apollo) - [Drug Modules](https://www.insight-rx.com/provider/drug-modules) ##### For Life Sciences - [Nova (MIPD for Clinical Trials)](https://www.insight-rx.com/life-sciences/nova) - [Astra (AI-Powered Clin Pharm)](https://www.insight-rx.com/life-sciences/astra) - [Companion Applications](https://www.insight-rx.com/life-sciences/nova#companion-applications) #### How We Do It ##### Platform - [Continuous Learning](https://www.insight-rx.com/platform/continuous-learning) - [Integrations](https://www.insight-rx.com/platform/integrations) - [Security & Regulatory](https://www.insight-rx.com/platform/security-regulatory) - [Success & Support](https://www.insight-rx.com/platform/success-support) ##### Science - [Data Science](https://www.insight-rx.com/data-science) - [Scientific Publications](https://www.insight-rx.com/data-science/scientific-publications) #### Information ##### Resources - [Success Stories](https://www.insight-rx.com/success-stories) - [White Papers](https://www.insight-rx.com/white-papers) - [Publications Using InsightRX](https://www.insight-rx.com/publications-using-insightrx-software) - [How to Cite InsightRX](https://www.insight-rx.com/how-to-cite-insightrx-nova) ##### Blog - [All Posts](https://blog.insight-rx.com/resources) - [Product Innovation](https://blog.insight-rx.com/resources?section=product_innovation) - [Thought Leadership](https://blog.insight-rx.com/resources?section=thought_leadership) #### About - [Our Story](https://www.insight-rx.com/about) - [Leadership](https://www.insight-rx.com/leadership) - [Advisory Board](https://www.insight-rx.com/advisory-board) - [Our Customers](https://www.insight-rx.com/customers) - [Press Releases](https://blog.insight-rx.com/press-releases?section=press_releases) - [Media](https://blog.insight-rx.com/press-releases?section=media) - [Careers](https://www.insight-rx.com/careers) - [Contact](https://www.insight-rx.com/contact-us) --- ![CE marking](https://blog.insight-rx.com/hubfs/ce-mark-white.svg) InsightRX Nova is HITRUST CSF r2 certified, CE marked, and 21 CFR Part 11 compliant. Our quality management, risk management, software lifecycle, and usability engineering processes conform to ISO 13485, IEC 62304, ISO 14971, IEC 62366-1, and IEC 82304-1. InsightRX Nova is not considered to be a medical device in the U.S. and has not been submitted to the U.S. Food and Drug Administration for review or clearance. 740-05000-REC-01 · 08/2025 --- [![InsightRX](https://blog.insight-rx.com/hubfs/insightrx_logo_white-teal.svg)](https://www.insight-rx.com/) 548 Market Street #88083 San Francisco, CA 94104 --- © 2026 InsightRX, Inc. All rights reserved. [Privacy Policy](https://www.insight-rx.com/privacy-policy) Cookie Preferences ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "InsightRX Communications", "url" : "https://blog.insight-rx.com/press-releases/author/insightrx" }, "dateModified" : "2025-12-15T00:45:50.767Z", "datePublished" : "2022-07-25T16:00:00.000Z", "headline" : "InsightRX Precision Medicine Software Platform Selected by Amsterdam UMC", "image" : [ "https://blog.insight-rx.com/hubfs/Logo-Amsterdam-UMC-1.png" ], "mainEntityOfPage" : { "@id" : "https://blog.insight-rx.com/press-releases/insightrx-precision-medicine-software-platform-selected-amsterdam-umc", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://blog.insight-rx.com/hubfs/insightrx_logo_color%20500%20x%20250-1.png" }, "name" : "InsightRX" } } ```